Evidence mapPaperPMID 39676570Full record

ArticleInternational health2025

Dengue and diabetes comorbidity: an emerging public health threat.

Donal Bisanzio, Cássia Fernanda Estofolete, Richard Reithinger

Abstract read
In one paragraph

Article in International health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Donal BisanzioInternational Development Group, RTI International, Washington D.C., USA.ORCID 0000-0002-7832-2291
Cássia Fernanda EstofoleteLaboratório de Pesquisas em Virologia, FAMERP, CREATE-NEO, São José do Rio Preto, São Paulo, Brazil.
Richard ReithingerInternational Development Group, RTI International, Washington D.C., USA.ORCID 0000-0001-5710-1556

Funding

Centers for Research in Emerging Infectious Diseases #2022/09229-0Centers for Research in Emerging Infectious Diseases #U01AI151378Centers for Research in Emerging Infectious Diseases #U01AI151807NIAID NIH HHS U01 AI151378NIAID NIH HHS U01 AI151807NIH HHS
6 · The paper itself

Abstract

Dengue is of growing global public health concern. Diabetes is a significant risk factor for severe dengue and dengue-related mortality. Countries with the highest number of reported dengue cases are projected to experience a substantial increase in diabetes by 2050. This likely will result in an increased incidence of dengue-diabetes comorbidity, and, hence, in severe dengue and dengue-related mortality. Countries that are or will be affected by a high burden for both diabetes and dengue should urgently design strategies to minimize the health and economic impact that a diabetes-dengue comorbidity could have on affected populations.

Indexed as

DengueDiabetes MellitusPublic HealthComorbidityGlobal HealthHumansIncidenceRisk Factors

Identifiers

PMID39676570
PMCPMC12212227

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.